Canada Lumasiran Market (2025-2031) | Growth, Trends, Segmentation, Size & Revenue, Forecast, Companies, Competitive Landscape, Share, Industry, Outlook, Analysis, Value

Market Forecast By Drug Class (Miscellaneous Metabolic Agents, others), By Application (Primary Hyperoxaluria, Others), By Dosage form (Injection, Solution), By Route of Administration (Subcutaneous, Demographic, Adult, Pediatric), By End-Users (Clinics, Hospitals, Diagnostic center), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) And Competitive Landscape
Product Code: ETC6660176 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Bhawna Singh No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • Canada Lumasiran Market Outlook
  • Market Size of Canada Lumasiran Market, 2024
  • Forecast of Canada Lumasiran Market, 2031
  • Historical Data and Forecast of Canada Lumasiran Revenues & Volume for the Period 2021- 2031
  • Canada Lumasiran Market Trend Evolution
  • Canada Lumasiran Market Drivers and Challenges
  • Canada Lumasiran Price Trends
  • Canada Lumasiran Porter's Five Forces
  • Canada Lumasiran Industry Life Cycle
  • Historical Data and Forecast of Canada Lumasiran Market Revenues & Volume By Drug Class for the Period 2021- 2031
  • Historical Data and Forecast of Canada Lumasiran Market Revenues & Volume By Miscellaneous Metabolic Agents for the Period 2021- 2031
  • Historical Data and Forecast of Canada Lumasiran Market Revenues & Volume By others for the Period 2021- 2031
  • Historical Data and Forecast of Canada Lumasiran Market Revenues & Volume By Application for the Period 2021- 2031
  • Historical Data and Forecast of Canada Lumasiran Market Revenues & Volume By Primary Hyperoxaluria for the Period 2021- 2031
  • Historical Data and Forecast of Canada Lumasiran Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of Canada Lumasiran Market Revenues & Volume By Dosage form for the Period 2021- 2031
  • Historical Data and Forecast of Canada Lumasiran Market Revenues & Volume By Injection for the Period 2021- 2031
  • Historical Data and Forecast of Canada Lumasiran Market Revenues & Volume By Solution for the Period 2021- 2031
  • Historical Data and Forecast of Canada Lumasiran Market Revenues & Volume By Route of Administration for the Period 2021- 2031
  • Historical Data and Forecast of Canada Lumasiran Market Revenues & Volume By Subcutaneous for the Period 2021- 2031
  • Historical Data and Forecast of Canada Lumasiran Market Revenues & Volume By Demographic for the Period 2021- 2031
  • Historical Data and Forecast of Canada Lumasiran Market Revenues & Volume By Adult for the Period 2021- 2031
  • Historical Data and Forecast of Canada Lumasiran Market Revenues & Volume By Pediatric for the Period 2021- 2031
  • Historical Data and Forecast of Canada Lumasiran Market Revenues & Volume By End-Users for the Period 2021- 2031
  • Historical Data and Forecast of Canada Lumasiran Market Revenues & Volume By Clinics for the Period 2021- 2031
  • Historical Data and Forecast of Canada Lumasiran Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of Canada Lumasiran Market Revenues & Volume By Diagnostic center for the Period 2021- 2031
  • Historical Data and Forecast of Canada Lumasiran Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
  • Historical Data and Forecast of Canada Lumasiran Market Revenues & Volume By Hospital Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of Canada Lumasiran Market Revenues & Volume By Retail Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of Canada Lumasiran Market Revenues & Volume By Online Pharmacy for the Period 2021- 2031
  • Canada Lumasiran Import Export Trade Statistics
  • Market Opportunity Assessment By Drug Class
  • Market Opportunity Assessment By Application
  • Market Opportunity Assessment By Dosage form
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By End-Users
  • Market Opportunity Assessment By Distribution Channel
  • Canada Lumasiran Top Companies Market Share
  • Canada Lumasiran Competitive Benchmarking By Technical and Operational Parameters
  • Canada Lumasiran Company Profiles
  • Canada Lumasiran Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the Canada Lumasiran Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Canada Lumasiran Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Canada Lumasiran Market Overview

3.1 Canada Country Macro Economic Indicators

3.2 Canada Lumasiran Market Revenues & Volume, 2021 & 2031F

3.3 Canada Lumasiran Market - Industry Life Cycle

3.4 Canada Lumasiran Market - Porter's Five Forces

3.5 Canada Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 Canada Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 Canada Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F

3.8 Canada Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.9 Canada Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F

3.10 Canada Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 Canada Lumasiran Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of rare diseases, such as Primary Hyperoxaluria Type 1 (PH1) which can be treated with lumasiran.

4.2.2 Growing awareness among healthcare professionals about the benefits of using lumasiran for treating rare genetic diseases.

4.2.3 Favorable government regulations and policies supporting the development and adoption of orphan drugs like lumasiran.

4.3 Market Restraints

4.3.1 High cost associated with lumasiran treatment may limit affordability and access for some patients.

4.3.2 Limited availability of healthcare facilities equipped to administer lumasiran injections.

4.3.3 Stringent regulatory requirements and approval processes for orphan drugs like lumasiran may delay market entry and adoption.

5 Canada Lumasiran Market Trends

6 Canada Lumasiran Market, By Types

6.1 Canada Lumasiran Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 Canada Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 Canada Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F

6.1.4 Canada Lumasiran Market Revenues & Volume, By others, 2021- 2031F

6.2 Canada Lumasiran Market, By Application

6.2.1 Overview and Analysis

6.2.2 Canada Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F

6.2.3 Canada Lumasiran Market Revenues & Volume, By Others, 2021- 2031F

6.3 Canada Lumasiran Market, By Dosage form

6.3.1 Overview and Analysis

6.3.2 Canada Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F

6.3.3 Canada Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F

6.4 Canada Lumasiran Market, By Route of Administration

6.4.1 Overview and Analysis

6.4.2 Canada Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F

6.4.3 Canada Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F

6.4.4 Canada Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F

6.4.5 Canada Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F

6.5 Canada Lumasiran Market, By End-Users

6.5.1 Overview and Analysis

6.5.2 Canada Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F

6.5.3 Canada Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.4 Canada Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F

6.6 Canada Lumasiran Market, By Distribution Channel

6.6.1 Overview and Analysis

6.6.2 Canada Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.6.3 Canada Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.6.4 Canada Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

7 Canada Lumasiran Market Import-Export Trade Statistics

7.1 Canada Lumasiran Market Export to Major Countries

7.2 Canada Lumasiran Market Imports from Major Countries

8 Canada Lumasiran Market Key Performance Indicators

8.1 Number of healthcare professionals trained in administering lumasiran injections.

8.2 Patient enrollment in clinical trials evaluating the efficacy and safety of lumasiran.

8.3 Adoption rate of lumasiran as a treatment option for rare genetic diseases in Canada.

9 Canada Lumasiran Market - Opportunity Assessment

9.1 Canada Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 Canada Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 Canada Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F

9.4 Canada Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.5 Canada Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F

9.6 Canada Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 Canada Lumasiran Market - Competitive Landscape

10.1 Canada Lumasiran Market Revenue Share, By Companies, 2024

10.2 Canada Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All
Chat With 6W AI Intelligence